EDAP TMS SA Cash Flow Conversion Efficiency

Latest as of March 2026: -0.294x

EDAP TMS SA cash flow conversion efficiency. Based on the latest financial reports, EDAP TMS SA (EDAP) has a cash flow conversion efficiency ratio of -0.294x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.97 Million) by net assets ($10.10 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of EDAP TMS SA (1997–2025)

Cash flow conversion efficiency of EDAP TMS SA from 1997 to 2025. This chart illustrates how EDAP TMS SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View EDAP TMS SA stock quote for real-time trading data and today's change.

EDAP TMS SA Cash Flow Conversion Ratio Explained

EDAP TMS SA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

EDAP TMS SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of EDAP TMS SA ranked by their cash flow conversion efficiency. Also see EDAP TMS SA market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Sunty Development Co Ltd
TW:3266
-0.061x
CMC Corp
VN:CMG
0.060x
Centrum Medyczne ENEL-MED SA
WAR:ENE
0.223x
Shane Global Holding Inc
TW:8482
0.060x
Lihtai Construction Enterprise Co Ltd
TWO:5520
0.054x
Israel Corp
TA:ILCO
0.038x
Cartesian Growth Corporation II Class A Ordinary Shares
NASDAQ:RENE
-0.007x
Akmerkez Gayrimenkul Yatirim Ortakligi AS
IS:AKMGY
0.014x

Annual Cash Flow Conversion Efficiency for EDAP TMS SA (1997–2025)

The table below shows the annual cash flow conversion efficiency of EDAP TMS SA from 1997 to 2025. Review EDAP free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $19.41 Million $-16.41 Million -0.845x -154.47%
2024-12-31 $40.90 Million $-13.58 Million -0.332x -28.82%
2023-12-31 $56.92 Million $-14.68 Million -0.258x -510.79%
2022-12-31 $71.63 Million $-3.02 Million -0.042x -147.54%
2021-12-31 $50.05 Million $4.45 Million 0.089x +3.42%
2020-12-31 $26.25 Million $2.25 Million 0.086x -38.18%
2019-12-31 $27.36 Million $3.80 Million 0.139x +1881.34%
2018-12-31 $24.96 Million $175.00K 0.007x +105.77%
2017-12-31 $25.16 Million $-3.06 Million -0.122x -365.69%
2016-12-31 $24.45 Million $1.12 Million 0.046x -50.64%
2015-12-31 $14.43 Million $1.34 Million 0.093x +238.45%
2014-12-31 $15.14 Million $-1.01 Million -0.067x +75.08%
2013-12-31 $9.28 Million $-2.50 Million -0.269x -1253.83%
2012-12-31 $8.16 Million $-162.00K -0.020x +76.53%
2011-12-31 $8.71 Million $-737.00K -0.085x +80.28%
2010-12-31 $8.90 Million $-3.82 Million -0.429x -47.28%
2009-12-31 $12.58 Million $-3.66 Million -0.291x -9.02%
2008-12-31 $17.19 Million $-4.59 Million -0.267x -41.95%
2007-12-31 $14.52 Million $-2.73 Million -0.188x -91.08%
2006-12-31 $19.30 Million $-1.90 Million -0.099x -500.94%
2005-12-31 $17.36 Million $-284.53K -0.016x +74.02%
2004-12-31 $17.95 Million $-1.13 Million -0.063x +67.23%
2003-12-31 $18.93 Million $-3.64 Million -0.192x +31.41%
2002-12-31 $28.40 Million $-7.97 Million -0.281x -221.04%
2001-12-31 $38.98 Million $-3.41 Million -0.087x -10295.04%
2000-12-31 $34.78 Million $29.81K 0.001x +100.52%
1999-12-31 $15.47 Million $-2.54 Million -0.164x +36.19%
1998-12-31 $24.90 Million $-6.39 Million -0.257x -2288.70%
1997-12-31 $33.82 Million $-363.64K -0.011x --

About EDAP TMS SA

NASDAQ:EDAP USA Medical Distribution
Market Cap
$203.71 Million
Market Cap Rank
#17343 Global
#4121 in USA
Share Price
$5.44
Change (1 day)
-0.18%
52-Week Range
$1.99 - $5.45
All Time High
$12.49
About

EDAP TMS S.A., a medical technology company, engages in the development, manufacturing, marketing, and sale of non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment de… Read more